STOCK TITAN

Dentsply Sirona Inc Stock Price, News & Analysis

XRAY Nasdaq

Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.

DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.

Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.

News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.

Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.

Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) has declared a quarterly cash dividend of $0.10 per share, indicating an annual rate of $0.40. The dividend will be payable on April 9, 2021 to stockholders on record as of March 26, 2021. As the largest manufacturer of professional dental products, Dentsply Sirona provides a comprehensive range of innovative solutions to enhance patient care and improve dental practices. This announcement reflects the company's ongoing commitment to returning value to its shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
dividends
-
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on March 1, 2021, at 8:30 am ET. An earnings press release will be issued earlier that morning. Investors can access the call via the company’s website and participate by calling +1-877-370-7637 (domestic) or +1-629-228-0723 (international) using Conference ID # 8540717. A replay will be available for a week. Dentsply Sirona, the largest manufacturer of dental products, focuses on advancing patient care through innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
conferences
-
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 AM ET. CEO Don Casey will represent the company during the event. Interested parties can access a live audio webcast of the presentation on their website. A replay will also be available afterward. Dentsply Sirona is the largest manufacturer of dental products and technologies, known for its innovation and quality in the dental industry, with a 132-year history.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
conferences
Rhea-AI Summary

Dentsply Sirona has acquired Byte for $1.04 billion, enhancing its position in the clear aligner market. This all-cash transaction is expected to accelerate growth and profitability in Dentsply's combined clear aligner business, with projected run-rate sales exceeding $300 million by the end of 2021. The acquisition is anticipated to be accretive to Dentsply's Non-GAAP EPS by at least $0.05 in 2021. Dentsply's CEO emphasizes the strategic importance of this deal, while Byte's management is set to continue operations under the Dentsply umbrella.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
-
Rhea-AI Summary

Dentsply Sirona (NASDAQ: XRAY) announced a quarterly cash dividend of $0.10 per share, indicating an annual rate of $0.40. The dividend is set for payment on January 8, 2021, to those on record by December 24, 2020. As the largest global manufacturer of professional dental products, Dentsply Sirona continues to advance dental care through its innovative products and technologies, supporting both the dental industry and patients worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
dividends
-
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) will participate in the 2020 Wolfe Research Virtual Healthcare Conference on November 19th, 2020. CEO Don Casey will represent the company in a fireside chat scheduled for 1:45 PM Eastern Time. Investors can access the live audio webcast through the Dentsply Sirona website, where a replay will also be available. Dentsply Sirona is a leading manufacturer of dental products with a strong history of innovation, aiming to enhance patient care through effective solutions. For more details, visit www.dentsplysirona.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.71%
Tags
conferences
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11, 2020. CEO Don Casey is scheduled to present at 8:45 AM ET. Investors can access a live webcast on the company's website, where a replay will also be available later. Dentsply Sirona is the largest manufacturer of professional dental products and technologies, with a strong focus on innovative solutions for patient care and dentistry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
conferences
-
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) reported Q3 2020 net sales of $895 million, a 7.0% decline year-over-year, with organic sales down 8.8%. GAAP operating income fell 25.4% to $82 million, while Non-GAAP operating income rose 14.3% to $197 million. GAAP EPS declined 34.2% to $0.25, although Non-GAAP EPS increased 17.5% to $0.67. Operating cash flow improved to $207 million from $159 million in 2019, and total cash on hand is $1.3 billion. The company has not provided guidance for the fiscal year due to COVID-19 uncertainties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
-
Rhea-AI Summary

Dentsply Sirona (NASDAQ:XRAY) will host an investor conference call and live webcast on November 5, 2020, at 8:30 am ET. The earnings press release will be issued earlier on the same day. Investors can join the webcast via Dentsply Sirona’s official website. For call participants, the U.S. dial-in number is +1-877-370-7637, and +1-629-228-0723 for international callers, using Conference ID # 2187918. A replay of the call will be available online and via dial-in for one week. Dentsply Sirona is the largest manufacturer of professional dental products globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
conferences earnings
Rhea-AI Summary

Dentsply Sirona (Nasdaq: XRAY) announced the appointment of Clyde R. Hosein to its Board of Directors, expanding the board to twelve members. Chairman Eric K. Brandt expressed enthusiasm for Hosein's operational finance and technology expertise, which aligns with the dental industry's digital transformation. CEO Don Casey emphasized Hosein's experience in high-tech management and operational execution, which is expected to strengthen the company's strategic position. Hosein brings over 30 years of technology experience, having held key financial roles in several major companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
management

FAQ

What is the current stock price of Dentsply Sirona (XRAY)?

The current stock price of Dentsply Sirona (XRAY) is $13.76 as of February 6, 2026.

What is the market cap of Dentsply Sirona (XRAY)?

The market cap of Dentsply Sirona (XRAY) is approximately 2.5B.
Dentsply Sirona Inc

Nasdaq:XRAY

XRAY Rankings

XRAY Stock Data

2.50B
198.89M
0.39%
104.2%
3.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE

XRAY RSS Feed